228 related articles for article (PubMed ID: 23018565)
1. Macrohematuria as initial presentation in a girl with factor VIII and factor IX inhibitors associated with systemic lupus erythematosus.
Shen CY; Fu LS; Lin HK; Han SM; Wang JD
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e344-5. PubMed ID: 23018565
[TBL] [Abstract][Full Text] [Related]
2. Acquired hemophilia in a patient with systemic lupus erythematosus: a case report and literature review.
Akahoshi M; Aizawa K; Nagano S; Inoue H; Sadanaga A; Arinobu Y; Niiro H; Nakashima H
Mod Rheumatol; 2008; 18(5):511-5. PubMed ID: 18551353
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
4. A therapeutic alternative for haemophiliacs with inhibitors.
Schulman S
Acta Paediatr; 1992; 81(6-7):564-5. PubMed ID: 1392376
[No Abstract] [Full Text] [Related]
5. [Macrohaematuria post-partum: an unusual case of acquired haemophilia after pregnancy].
Prencipe MA; D'Errico M; Di Giorgio G; Gatta G; Gesuete A; Nobile M; Stallone C
G Ital Nefrol; 2002; 19(2):204-8. PubMed ID: 12195420
[TBL] [Abstract][Full Text] [Related]
6. Recombinant clotting factors in the treatment of hemophilia.
Lee C
Thromb Haemost; 1999 Aug; 82(2):516-24. PubMed ID: 10605745
[No Abstract] [Full Text] [Related]
7. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
8. Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors.
Abshire T; Kenet G
Haemophilia; 2008 Sep; 14(5):898-902. PubMed ID: 18684126
[TBL] [Abstract][Full Text] [Related]
9. Acquired haemophilia A in a woman with autoimmune hepatitis and systemic lupus erythematosus: review of literature.
Rezaieyazdi Z; Sharifi-Doloui D; Hashemzadeh K; Shirdel A; Mansouritorghabeh H
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):738-41. PubMed ID: 21885954
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based use of recombinant FVIIa (NovoSeven, NiaStase) for the treatment of hemophilia with inhibitors in children and adolescents.
Goldstein B; Geldziler B; Bjerre J; Seremetis S
Transfus Apher Sci; 2008 Feb; 38(1):25-32. PubMed ID: 18267372
[TBL] [Abstract][Full Text] [Related]
11. Acquired Hemophilia as Initial Presentation in a Patient with Systemic Lupus Erythematosus.
Khodamoradi Z; Nazarinia MA; Bazdar S
Curr Rheumatol Rev; 2017; 13(3):236-238. PubMed ID: 28523993
[TBL] [Abstract][Full Text] [Related]
12. Switching haemophilia products and inhibitor risk: a United States' perspective.
Nance D; Rodgers GM
Eur J Haematol; 2015 Apr; 94(4):283. PubMed ID: 25800968
[No Abstract] [Full Text] [Related]
13. A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors.
Chuansumrit A; Sri-Udomporn N; Srimuninnimit V; Juntarukha R
Haemophilia; 2001 Sep; 7(5):532-4. PubMed ID: 11554948
[No Abstract] [Full Text] [Related]
14. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR;
Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
[No Abstract] [Full Text] [Related]
15. The management of hemophilia patients with inhibitors.
Nilsson IM
Transfus Med Rev; 1992 Oct; 6(4):285-93. PubMed ID: 1421831
[No Abstract] [Full Text] [Related]
16. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
[TBL] [Abstract][Full Text] [Related]
17. Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.
Valentino LA; Cooper DL; Goldstein B
Haemophilia; 2011 Jul; 17(4):579-89. PubMed ID: 21294815
[TBL] [Abstract][Full Text] [Related]
18. Acquired a haemophilia: a case report.
Cinotti E; Trovato E; Fimiani M; Rubegni P
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):e106-e107. PubMed ID: 28924993
[No Abstract] [Full Text] [Related]
19. Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg⁻¹) rFVIIa doses across clinical trials and registries.
Shapiro AD; Neufeld EJ; Blanchette V; Salaj P; Gut RZ; Cooper DL
Haemophilia; 2014 Jan; 20(1):e23-31. PubMed ID: 24354484
[TBL] [Abstract][Full Text] [Related]
20. Acquired hemophilia A in a woman with systemic lupus erythematosus: A case report and review of literature.
Shen P; Li J; Tu S; Chen G; Chen C
Medicine (Baltimore); 2020 Oct; 99(43):e22926. PubMed ID: 33120848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
